A great deal of rain has finally given way to clear skies here in the nation's medicine chest. And the evening, of course, means many things: time to take out the trash, check the homework and tidy up a bit around the castle. Then, there are more documents to digest. Tomorrow, after all, is just around the corner. Meanwhile, let's not forget these...
· Amgen To Pay $240 Million For Kidney Drug Company (Yahoo/Reuters)
· Novartis Gleevec Ruling Expected Next Week In India (Economic Times)
· Regeneron Stumbles On Mediocre Data (Forbes)
· Telik Says Cancer Patients Die Sooner On Its Drug (Bloomberg News)